According to the IMARC Group, the carotid artery disease market is projected at a CAGR of 3.03% during 2024-2034. This can be attributed to the continuous developments in endovascular techniques, like the introduction of transcarotid artery revascularization as well as transradial carotid artery stenting, which are less invasive with less likelihood of side effects. Carotid […]